Skip to main content

Table 1 Clinical, tumor and treatment characteristics

From: Clinical experience with 18F-JK-PSMA-7 when using a digital PET/CT

  PSA < 2 PSA ≥ 2 Total
Number of patients 30 24 54
Age (mean ± SD; range) 71.29 ± 6.55; 55–88 73.20 ± 8.33; 50–90 72 ± 7.43; 55–90
PSA (mean ± SD) 0.76 ± 0.56 10.26 ± 9.89 4.99 ± 8.08
PRT 22 16 38
Brachytherapy 0 4 4
Radiotherapy on the prostatic region 12 8 20
Hormonal therapy 0 32 32
Chemotherapy 0 8 8
Other treatment 0 6 6
PSMA +  16 22 38
PSMA- 14 2 16
Number of patients with lesions in prostatic region 8 7 15
Number of patients with lesions in pelvic lymph nodes 9 8 17